BioNTech SE (BNTX)

BioNTech SE Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	3,153	2,751	3,819	17,311	18,977	482.3
Revenue Growth (YoY)	3.70%	-27.96%	-77.94%	-8.78%	3834.63%	344.11%
Cost of Revenue	552	541.3	599.8	2,995	2,912	59.3
Gross Profit	2,601	2,210	3,219	14,316	16,065	423
Selling, General & Admin	538.6	599	557.7	541.2	327.2	108.5
Research & Development	2,211	2,254	1,783	1,537	949.2	645
Other Operating Expenses	755.3	642.1	-93.4	319.1	-57.7	-9.1
Operating Expenses	3,505	3,495	2,247	2,397	1,219	744.4
Operating Income	-904.7	-1,286	971.8	11,918	14,847	-321.4
Interest Expense	-237.9	-12.6	-7.9	-18.9	-27.3	-2
Interest & Investment Income	-	-	-	-	1.5	1.6
Currency Exchange Gain (Loss)	100.4	100.4	-268	792.4	512.5	-42.6
Other Non Operating Income (Expenses)	633.7	633.7	519.6	265.3	-277.8	-20.4
EBT Excluding Unusual Items	-408.5	-564	1,216	12,957	15,055	-384.8
Legal Settlements	-113.7	-113.7	-29.4	-3	-9	-
Other Unusual Items	-	-	-	-	-	239
Pretax Income	-522.2	-677.7	1,186	12,954	15,046	-145.8
Income Tax Expense	49.4	-12.4	255.8	3,520	4,754	-161
Earnings From Continuing Operations	-571.6	-665.3	930.3	9,434	10,293	15.2
Net Income to Company	-	-665.3	930.3	9,434	10,293	15.2
Net Income	-571.6	-665.3	930.3	9,434	10,293	15.2
Net Income to Common	-571.6	-665.3	930.3	9,434	10,293	15.2
Net Income Growth	-	-	-90.14%	-8.34%	67613.82%	-
Shares Outstanding (Basic)	240	240	241	243	244	235
Shares Outstanding (Diluted)	240	240	243	250	260	249
Shares Change (YoY)	-0.40%	-0.95%	-2.84%	-3.81%	4.51%	17.49%
EPS (Basic)	-2.38	-2.77	3.87	38.78	42.18	0.06
EPS (Diluted)	-2.38	-2.77	3.83	37.77	39.63	0.06
EPS Growth	-	-	-89.86%	-4.69%	65950.00%	-
Free Cash Flow	-495.3	-78.8	5,121	13,248	762.2	-79.5
Free Cash Flow Per Share	-2.06	-0.33	21.10	53.03	2.94	-0.32
Gross Margin	82.49%	80.32%	84.29%	82.70%	84.66%	87.70%
Operating Margin	-28.70%	-46.73%	25.45%	68.85%	78.23%	-66.64%
Profit Margin	-18.13%	-24.18%	24.36%	54.50%	54.24%	3.15%
Free Cash Flow Margin	-15.71%	-2.86%	134.10%	76.53%	4.02%	-16.48%
EBITDA	-566.9	-1,033	1,110	11,983	14,893	-289
EBITDA Margin	-17.98%	-37.55%	29.07%	69.22%	78.48%	-59.92%
D&A For EBITDA	337.8	252.4	138.2	64.5	46.2	32.4
EBIT	-904.7	-1,286	971.8	11,918	14,847	-321.4
EBIT Margin	-28.70%	-46.73%	25.45%	68.85%	78.23%	-66.64%
Effective Tax Rate	-	-	21.57%	27.17%	31.60%	-
Revenue as Reported	-	-	-	-	18,977	482.3

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q